Sphera Funds Management’s Medicines Co MDCO Stock Holding History

Sphera Funds Management’s Portfolio MDCO Stock Details MDCO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	–	Sell	-60,000	Closed	-$2.24M	–	134
2015 Q4	$2.24M	Buy	+60,000	New	+$2.27M	0.33%	77
2015 Q3	–	Sell	-180,000	Closed	-$5.15M	–	154
2015 Q2	$5.15M	Buy	180,000 +80,000	+80%	+$2.23M	0.5%	40
2015 Q1	$2.8M	Hold	100,000	–	–	0.29%	88
2014 Q4	$2.77M	Buy	+100,000	New	+$2.48M	0.47%	74
2014 Q1	–	Sell	-44,000	Closed	-$1.7M	–	142
2013 Q4	$1.7M	Buy	+44,000	New	+$1.57M	0.47%	56

Other funds holding MDCO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bridger Management New York $128M AUM 9.54% 1-Year Est. Return

Corvex Management New York $2.52B AUM 25.53% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Sphera Funds Management's MDCO Position: Q1 2016 in Review

Sphera Funds Management sold out of Medicines Co (MDCO) in Q1 2016, closing a stake of 60,000 shares — an estimated $2.24M sold.

Sphera Funds Management first reported a position in MDCO in Q4 2013 and held it in 5 quarters. The position peaked at $5.15M in Q2 2015. 181 funds tracked by Wall St. Rank hold MDCO as of Q1 2016.

Sphera Funds Management reported no remaining Medicines Co position as of Q1 2016 after selling out during the quarter.
Sphera Funds Management sold 60,000 Medicines Co shares in Q1 2016, an estimated $2.24M.
Sphera Funds Management first reported a position in Medicines Co in Q4 2013 and held it in 5 quarters.
Sphera Funds Management's Medicines Co position peaked at $5.15M in Q2 2015.
181 funds tracked by Wall St. Rank held Medicines Co as of Q1 2016.

Based on Sphera Funds Management's 13F filing for Q1 2016, filed 16 May 2016.